Difficulty: Medium
Average Score: 65%
Practice
Rivastigmine tachycardia likely due to the antiparkinson therapy. Which of the following actions most likely mediate the adverse effect reported by the patient?
Correct answer
B
Rationale
The adverse effect of tachycardia in this case is likely mediated by the decreased acetylcholine release from cholinergic terminals. Rivastigmine is a cholinesterase inhibitor used to treat Alzheimer's disease, and blocking the breakdown of acetylcholine can lead to cholinergic overstimulation, resulting in tachycardia.